# LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

> **NCT04409275** · — · UNKNOWN · sponsor: **Fundación para la Investigación del Hospital Clínico de Valencia** · enrollment: 500 (estimated)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04409275
- **Lead sponsor:** Fundación para la Investigación del Hospital Clínico de Valencia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-21
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04409275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04409275, "LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04409275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*